Patents by Inventor Shawn M. BEARSON

Shawn M. BEARSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190322707
    Abstract: A novel, mutated Salmonella enterica serovar Typhimurium vaccine is generated and imparts protective immunity in vaccinated animals for a range of S. enterica serovars. The vaccine can be attenuated or inactivated, including bacterial ghosts or membrane fractions thereof. Immunogenic compositions are included in the invention and methods of generating an immune response.
    Type: Application
    Filed: May 31, 2019
    Publication date: October 24, 2019
    Inventors: Bradley L. Bearson, Shawn M. Bearson
  • Patent number: 10351606
    Abstract: A novel, mutated Salmonella enterica serovar Typhimurium vaccine is generated and imparts protective immunity in vaccinated animals for a range of S. enterica serovars. The vaccine can be attenuated or inactivated, including bacterial ghosts or membrane fractions thereof. Immunogenic compositions are included in the invention and methods of generating an immune response.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: July 16, 2019
    Assignee: The United States of America, as Represented by the Secretary of Agriculture
    Inventors: Bradley L. Bearson, Shawn M. Bearson
  • Publication number: 20180086794
    Abstract: A novel, mutated Salmonella enterica serovar Typhimurium vaccine is generated and imparts protective immunity in vaccinated animals for a range of S. enterica serovars. The vaccine can be attenuated or inactivated, including bacterial ghosts or membrane fractions thereof. Immunogenic compositions are included in the invention and methods of generating an immune response.
    Type: Application
    Filed: December 7, 2017
    Publication date: March 29, 2018
    Inventors: Bradley L. Bearson, Shawn M. Bearson
  • Patent number: 9868769
    Abstract: A novel, mutated Salmonella enterica serovar Typhimurium vaccine is generated and imparts protective immunity in vaccinated animals for a range of S. enterica serovars. The vaccine can be attenuated or inactivated, including bacterial ghosts or membrane fractions thereof. Immunogenic compositions are included in the invention and methods of generating an immune response.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: January 16, 2018
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Bradley L. Bearson, Shawn M. Bearson
  • Publication number: 20170008935
    Abstract: A novel, mutated Salmonella enterica serovar Typhimurium vaccine is generated and imparts protective immunity in vaccinated animals for a range of S. enterica serovars. The vaccine can be attenuated or inactivated, including bacterial ghosts or membrane fractions thereof. Immunogenic compositions are included in the invention and methods of generating an immune response.
    Type: Application
    Filed: December 29, 2014
    Publication date: January 12, 2017
    Inventors: Bradley L. BEARSON, Shawn M. BEARSON